Biologics & Biosimilars: What Matters to Physicians?
Biologics & Biosimilars: Do Physicians Understand the Differences?

2017

2016

Biologics & Biosimilars: What Matters to Physicians?
Biologics & Biosimilars: Do Physicians Understand the Differences?
Differences in Physicians’ Understanding of Biologics and Biosimilars in the US and Europe
Fast Facts: Impact of High Cholesterol
Fast Facts: Pharmacovigilance

2019

2017

Fast Facts: Impact of High Cholesterol
Fast Facts: Pharmacovigilance
Pharmacovigilance in the UK
Pharmacovigilance in Portugal
Pharmacovigilance in Poland
Pharmacovigilance in Germany
Pharmacovigilance in France
Pharmacovigilance in Finland
Rheumatoid Arthritis: Access, Policy and Advocacy Goals
The Role of Drug Donations in Expanding Access to Medicines (Disponible en español)

2017

2016

Rheumatoid Arthritis: Access, Policy and Advocacy Goals
The Role of Drug Donations in Expanding Access to Medicines (Disponible en español)
Nor-Switch
5 Policy Principles to Improve Access for Patients with Rheumatoid Arthritis
Chronic Pain in Europe

2017

5 Policy Principles to Improve Access for Patients with Rheumatoid Arthritis
Chronic Pain in Europe

How to Talk to Your Health Care Provider About Rheumatoid Arthritis

Ver en español
Voir en français
Guarda in italiano
Auf deutsch ansehen

High Cholesterol in Europe